Global gene expression profiling of renal scarring in a rat model of pyelonephritis

被引:4
作者
Ichino, Manabu [1 ,2 ]
Mori, Terumi [2 ,3 ]
Kusaka, Mamoru [1 ,2 ]
Kuroyanagi, Yoko [1 ,2 ]
Ishikawa, Kiyohito [1 ]
Shiroki, Ryoichi [1 ]
Kowa, Hiroe [2 ,3 ]
Kurahashi, Hiroki [2 ,3 ]
Hoshinaga, Kiyotaka [1 ,2 ]
机构
[1] Fujita Hlth Univ, Sch Med, Dept Urol, Toyoake, Aichi 4701192, Japan
[2] Fujita Hlth Univ, Dev Ctr Targeted & Minimally Invas Diag & Treatme, 21st Century COE Program, Toyoake, Aichi 4701192, Japan
[3] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Toyoake, Aichi 4701192, Japan
关键词
vesicoureteral reflux; urinary tract infection; renal scarring; expression profiling; microarray; biomarker;
D O I
10.1007/s00467-007-0717-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Renal scarring is a serious complication of chronic pyelonephritis that occurs due to vesicoureteral reflux. In our study, we performed global expression profiling of the kidney during renal scarring formation in a rat pyelonephritis model. An inoculum of Escherichia coli was injected directly into the renal cortex. Histologically, renal scarring developed during the 3-to-4 week period after injection. The time-course expression profile of 18,442 genes was then analyzed using microarrays, followed by validation with real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Most of the genes found to be up-regulated during renal scarring are associated with immune and defense responses, including cytokines, chemokines and their receptors, complement factors, adhesion molecules and extracellular matrix proteins. These genes were up-regulated as early as 1 week after injection, when no fibrotic changes were yet evident, peaked at 2 weeks, and gradually decreased thereafter. However, a subset of cytokine genes was found to be persistently activated even at 6 weeks after injection, including interleukin (IL)-1 beta, transforming growth factor (TGF)-beta, and IL-3. Further statistical analysis indicated that the pathways mediated by these cytokines are activated concomitantly with renal scarring formation. The products of these genes may thus potentially be novel non-invasive diagnostic or prognostic biomarkers of renal scarring.
引用
收藏
页码:1059 / 1071
页数:13
相关论文
共 29 条
[1]   INTERLEUKIN-8 AND THE NEUTROPHIL RESPONSE TO MUCOSAL GRAM-NEGATIVE INFECTION [J].
AGACE, WW ;
HEDGES, SR ;
CESKA, M ;
SVANBORG, C .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) :780-785
[2]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[3]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[4]   No further development of renal scarring after antireflux surgery in children with primary vesicoureteral reflux:: Review of the results of 99mtechnetium dimercapto-succinic acid renal scan [J].
Choi, H ;
Oh, SJ ;
So, Y ;
Lee, DS ;
Lee, A ;
Kim, KM .
JOURNAL OF UROLOGY, 1999, 162 (03) :1189-1192
[5]   URINARY IMMUNOGLOBULINS IN HEALTHY-INDIVIDUALS AND CHILDREN WITH ACUTE PYELONEPHRITIS [J].
EDEN, CS ;
KULHAVY, R ;
MARILD, S ;
PRINCE, SJ ;
MESTECKY, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1985, 21 (04) :305-313
[6]   Renal mRNA levels as prognostic tools in kidney diseases [J].
Eikmans, M ;
Baelde, HJ ;
Hagen, EC ;
Paul, LC ;
Eilers, PHC ;
De Heer, E ;
Bruijn, JA .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (04) :899-907
[7]   RNA expression profiling as prognostic tool in renal patients: Toward nephrogenomics [J].
Eikmans, M ;
Baelde, HJ ;
De Heer, E ;
Bruijn, JA .
KIDNEY INTERNATIONAL, 2002, 62 (04) :1125-1135
[8]   Chronic kidney disease: the global challenge [J].
El Nahas, AM ;
Bello, AK .
LANCET, 2005, 365 (9456) :331-340
[9]   Plasma and urinary soluble adhesion molecule expression is increased during first documented acute pyelonephritis [J].
Gbadegesin, RA ;
Cotton, SA ;
Coupes, BM ;
Awan, A ;
Brenchley, PEC ;
Webb, NJA .
ARCHIVES OF DISEASE IN CHILDHOOD, 2002, 86 (03) :218-221
[10]   MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy [J].
Grandaliano, G ;
Gesualdo, L ;
Bartoli, F ;
Ranieri, E ;
Monno, R ;
Leggio, A ;
Paradies, G ;
Caldarulo, E ;
Infante, B ;
Schena, FP .
KIDNEY INTERNATIONAL, 2000, 58 (01) :182-192